img

Global OTC Veterinary Drug Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global OTC Veterinary Drug Market Insights, Forecast to 2034

Over-the-counter (OTC) veterinary drugs are medications that can be purchased directly by pet owners without a prescription from a veterinarian. These medications are typically used for the treatment and management of minor health conditions in animals.
Market Analysis and InsightsGlobal OTC Veterinary Drug Market
Global OTC Veterinary Drug market is expected to reach to US$ 8800 million in 2024, with a positive growth of %, compared with US$ 8421 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, OTC Veterinary Drug industry is evaluated to reach US$ 13890 million in 2034. The CAGR will be 7.9% during 2024 to 2034.
The increased demand for un-prescribed veterinary drugs, higher pet adoption, and humanization, expanding pet accessories, and vet medical stores are flourishing the demand for over-the-cover veterinary drugs.
Report Covers
This report presents an overview of global OTC Veterinary Drug market from 2018 to 2034, aiming to help readers to get a comprehensive understanding of global OTC Veterinary Drug market with multiple angles. Items like regional revenue from 2018 to 2034 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2034 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Zoetis
Boehringer Ingelheim
Virbac S.A.
Hester Biosciences Ltd.
Merck Animal Health
Elanco Animal Health
Ceva Santé Animale
Vetoquinol S.A.
Phibro Animal Health Corporation
Dechra Pharmaceuticals PLC
Segment by Type
Oral
Injectable
Topical
Others

Segment by Application


Veterinary Hospitals
Veterinary Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2034
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2034 globally
Chapter 5Product revenue analysis by application from 2018 to 2034 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2034 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2034
Chapter 7Product revenue analysis by type and application from 2018 to 2034 in Europe. Product revenue analysis of each country in Europe from 2018 to 2034
Chapter 8Product revenue analysis by type and application from 2018 to 2034 in China. Product revenue analysis of China from 2018 to 2034
Chapter 9Product revenue analysis by type and application from 2018 to 2034 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2034
Chapter 10Product revenue analysis by type and application from 2018 to 2034 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2034.
Chapter 11Companies’ outline, covering company’s basic information, major business, OTC Veterinary Drug introduction, etc. OTC Veterinary Drug Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12QYResearch’s Conclusions of OTC Veterinary Drug
Chapter 13Methodology and Data Sources adopted by QYResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global OTC Veterinary Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Oral
1.2.3 Injectable
1.2.4 Topical
1.2.5 Others
1.3 Market by Application
1.3.1 Global OTC Veterinary Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Veterinary Hospitals
1.3.3 Veterinary Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global OTC Veterinary Drug Market Perspective (2018-2034)
2.2 Global OTC Veterinary Drug Growth Trends by Region
2.2.1 OTC Veterinary Drug Market Size by Region: 2018 VS 2022 VS 2034
2.2.2 OTC Veterinary Drug Historic Market Size by Region (2018-2024)
2.2.3 OTC Veterinary Drug Forecasted Market Size by Region (2024-2034)
2.3 OTC Veterinary Drug Market Dynamics
2.3.1 OTC Veterinary Drug Industry Trends
2.3.2 OTC Veterinary Drug Market Drivers
2.3.3 OTC Veterinary Drug Market Challenges
2.3.4 OTC Veterinary Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue OTC Veterinary Drug by Players
3.1.1 Global OTC Veterinary Drug Revenue by Players (2018-2024)
3.1.2 Global OTC Veterinary Drug Revenue Market Share by Players (2018-2024)
3.2 Global OTC Veterinary Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of OTC Veterinary Drug, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global OTC Veterinary Drug Market Concentration Ratio
3.4.1 Global OTC Veterinary Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by OTC Veterinary Drug Revenue in 2022
3.5 Global Key Players of OTC Veterinary Drug Head office and Area Served
3.6 Global Key Players of OTC Veterinary Drug, Product and Application
3.7 Global Key Players of OTC Veterinary Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 OTC Veterinary Drug Breakdown Data by Type
4.1 Global OTC Veterinary Drug Historic Market Size by Type (2018-2024)
4.2 Global OTC Veterinary Drug Forecasted Market Size by Type (2024-2034)
5 OTC Veterinary Drug Breakdown Data by Application
5.1 Global OTC Veterinary Drug Historic Market Size by Application (2018-2024)
5.2 Global OTC Veterinary Drug Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America OTC Veterinary Drug Market Size (2018-2034)
6.2 North America OTC Veterinary Drug Market Size by Type
6.2.1 North America OTC Veterinary Drug Market Size by Type (2018-2024)
6.2.2 North America OTC Veterinary Drug Market Size by Type (2024-2034)
6.2.3 North America OTC Veterinary Drug Market Share by Type (2018-2034)
6.3 North America OTC Veterinary Drug Market Size by Application
6.3.1 North America OTC Veterinary Drug Market Size by Application (2018-2024)
6.3.2 North America OTC Veterinary Drug Market Size by Application (2024-2034)
6.3.3 North America OTC Veterinary Drug Market Share by Application (2018-2034)
6.4 North America OTC Veterinary Drug Market Size by Country
6.4.1 North America OTC Veterinary Drug Market Size by Country: 2018 VS 2022 VS 2034
6.4.2 North America OTC Veterinary Drug Market Size by Country (2018-2024)
6.4.3 North America OTC Veterinary Drug Market Size by Country (2024-2034)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe OTC Veterinary Drug Market Size (2018-2034)
7.2 Europe OTC Veterinary Drug Market Size by Type
7.2.1 Europe OTC Veterinary Drug Market Size by Type (2018-2024)
7.2.2 Europe OTC Veterinary Drug Market Size by Type (2024-2034)
7.2.3 Europe OTC Veterinary Drug Market Share by Type (2018-2034)
7.3 Europe OTC Veterinary Drug Market Size by Application
7.3.1 Europe OTC Veterinary Drug Market Size by Application (2018-2024)
7.3.2 Europe OTC Veterinary Drug Market Size by Application (2024-2034)
7.3.3 Europe OTC Veterinary Drug Market Share by Application (2018-2034)
7.4 Europe OTC Veterinary Drug Market Size by Country
7.4.1 Europe OTC Veterinary Drug Market Size by Country: 2018 VS 2022 VS 2034
7.4.2 Europe OTC Veterinary Drug Market Size by Country (2018-2024)
7.4.3 Europe OTC Veterinary Drug Market Size by Country (2024-2034)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China OTC Veterinary Drug Market Size (2018-2034)
8.2 China OTC Veterinary Drug Market Size by Type
8.2.1 China OTC Veterinary Drug Market Size by Type (2018-2024)
8.2.2 China OTC Veterinary Drug Market Size by Type (2024-2034)
8.2.3 China OTC Veterinary Drug Market Share by Type (2018-2034)
8.3 China OTC Veterinary Drug Market Size by Application
8.3.1 China OTC Veterinary Drug Market Size by Application (2018-2024)
8.3.2 China OTC Veterinary Drug Market Size by Application (2024-2034)
8.3.3 China OTC Veterinary Drug Market Share by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia OTC Veterinary Drug Market Size (2018-2034)
9.2 Asia OTC Veterinary Drug Market Size by Type
9.2.1 Asia OTC Veterinary Drug Market Size by Type (2018-2024)
9.2.2 Asia OTC Veterinary Drug Market Size by Type (2024-2034)
9.2.3 Asia OTC Veterinary Drug Market Share by Type (2018-2034)
9.3 Asia OTC Veterinary Drug Market Size by Application
9.3.1 Asia OTC Veterinary Drug Market Size by Application (2018-2024)
9.3.2 Asia OTC Veterinary Drug Market Size by Application (2024-2034)
9.3.3 Asia OTC Veterinary Drug Market Share by Application (2018-2034)
9.4 Asia OTC Veterinary Drug Market Size by Region
9.4.1 Asia OTC Veterinary Drug Market Size by Region: 2018 VS 2022 VS 2034
9.4.2 Asia OTC Veterinary Drug Market Size by Region (2018-2024)
9.4.3 Asia OTC Veterinary Drug Market Size by Region (2024-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America OTC Veterinary Drug Market Size (2018-2034)
10.2 Middle East, Africa, and Latin America OTC Veterinary Drug Market Size by Type
10.2.1 Middle East, Africa, and Latin America OTC Veterinary Drug Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America OTC Veterinary Drug Market Size by Type (2024-2034)
10.2.3 Middle East, Africa, and Latin America OTC Veterinary Drug Market Share by Type (2018-2034)
10.3 Middle East, Africa, and Latin America OTC Veterinary Drug Market Size by Application
10.3.1 Middle East, Africa, and Latin America OTC Veterinary Drug Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America OTC Veterinary Drug Market Size by Application (2024-2034)
10.3.3 Middle East, Africa, and Latin America OTC Veterinary Drug Market Share by Application (2018-2034)
10.4 Middle East, Africa, and Latin America OTC Veterinary Drug Market Size by Country
10.4.1 Middle East, Africa, and Latin America OTC Veterinary Drug Market Size by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa, and Latin America OTC Veterinary Drug Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America OTC Veterinary Drug Market Size by Country (2024-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Zoetis
11.1.1 Zoetis Company Details
11.1.2 Zoetis Business Overview
11.1.3 Zoetis OTC Veterinary Drug Introduction
11.1.4 Zoetis Revenue in OTC Veterinary Drug Business (2018-2024)
11.1.5 Zoetis Recent Developments
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Details
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim OTC Veterinary Drug Introduction
11.2.4 Boehringer Ingelheim Revenue in OTC Veterinary Drug Business (2018-2024)
11.2.5 Boehringer Ingelheim Recent Developments
11.3 Virbac S.A.
11.3.1 Virbac S.A. Company Details
11.3.2 Virbac S.A. Business Overview
11.3.3 Virbac S.A. OTC Veterinary Drug Introduction
11.3.4 Virbac S.A. Revenue in OTC Veterinary Drug Business (2018-2024)
11.3.5 Virbac S.A. Recent Developments
11.4 Hester Biosciences Ltd.
11.4.1 Hester Biosciences Ltd. Company Details
11.4.2 Hester Biosciences Ltd. Business Overview
11.4.3 Hester Biosciences Ltd. OTC Veterinary Drug Introduction
11.4.4 Hester Biosciences Ltd. Revenue in OTC Veterinary Drug Business (2018-2024)
11.4.5 Hester Biosciences Ltd. Recent Developments
11.5 Merck Animal Health
11.5.1 Merck Animal Health Company Details
11.5.2 Merck Animal Health Business Overview
11.5.3 Merck Animal Health OTC Veterinary Drug Introduction
11.5.4 Merck Animal Health Revenue in OTC Veterinary Drug Business (2018-2024)
11.5.5 Merck Animal Health Recent Developments
11.6 Elanco Animal Health
11.6.1 Elanco Animal Health Company Details
11.6.2 Elanco Animal Health Business Overview
11.6.3 Elanco Animal Health OTC Veterinary Drug Introduction
11.6.4 Elanco Animal Health Revenue in OTC Veterinary Drug Business (2018-2024)
11.6.5 Elanco Animal Health Recent Developments
11.7 Ceva Santé Animale
11.7.1 Ceva Santé Animale Company Details
11.7.2 Ceva Santé Animale Business Overview
11.7.3 Ceva Santé Animale OTC Veterinary Drug Introduction
11.7.4 Ceva Santé Animale Revenue in OTC Veterinary Drug Business (2018-2024)
11.7.5 Ceva Santé Animale Recent Developments
11.8 Vetoquinol S.A.
11.8.1 Vetoquinol S.A. Company Details
11.8.2 Vetoquinol S.A. Business Overview
11.8.3 Vetoquinol S.A. OTC Veterinary Drug Introduction
11.8.4 Vetoquinol S.A. Revenue in OTC Veterinary Drug Business (2018-2024)
11.8.5 Vetoquinol S.A. Recent Developments
11.9 Phibro Animal Health Corporation
11.9.1 Phibro Animal Health Corporation Company Details
11.9.2 Phibro Animal Health Corporation Business Overview
11.9.3 Phibro Animal Health Corporation OTC Veterinary Drug Introduction
11.9.4 Phibro Animal Health Corporation Revenue in OTC Veterinary Drug Business (2018-2024)
11.9.5 Phibro Animal Health Corporation Recent Developments
11.10 Dechra Pharmaceuticals PLC
11.10.1 Dechra Pharmaceuticals PLC Company Details
11.10.2 Dechra Pharmaceuticals PLC Business Overview
11.10.3 Dechra Pharmaceuticals PLC OTC Veterinary Drug Introduction
11.10.4 Dechra Pharmaceuticals PLC Revenue in OTC Veterinary Drug Business (2018-2024)
11.10.5 Dechra Pharmaceuticals PLC Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global OTC Veterinary Drug Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2034
Table 2. Key Players of Oral
Table 3. Key Players of Injectable
Table 4. Key Players of Topical
Table 5. Key Players of Others
Table 6. Global OTC Veterinary Drug Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2034
Table 7. Global OTC Veterinary Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 8. Global OTC Veterinary Drug Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global OTC Veterinary Drug Market Share by Region (2018-2024)
Table 10. Global OTC Veterinary Drug Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 11. Global OTC Veterinary Drug Market Share by Region (2024-2034)
Table 12. OTC Veterinary Drug Market Trends
Table 13. OTC Veterinary Drug Market Drivers
Table 14. OTC Veterinary Drug Market Challenges
Table 15. OTC Veterinary Drug Market Restraints
Table 16. Global OTC Veterinary Drug Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global OTC Veterinary Drug Revenue Share by Players (2018-2024)
Table 18. Global Top OTC Veterinary Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Veterinary Drug as of 2022)
Table 19. Global OTC Veterinary Drug Industry Ranking 2021 VS 2022 VS 2024
Table 20. Global 5 Largest Players Market Share by OTC Veterinary Drug Revenue (CR5 and HHI) & (2018-2024)
Table 21. Global Key Players of OTC Veterinary Drug, Headquarters and Area Served
Table 22. Global Key Players of OTC Veterinary Drug, Product and Application
Table 23. Global Key Players of OTC Veterinary Drug, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global OTC Veterinary Drug Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global OTC Veterinary Drug Revenue Market Share by Type (2018-2024)
Table 27. Global OTC Veterinary Drug Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 28. Global OTC Veterinary Drug Revenue Market Share by Type (2024-2034)
Table 29. Global OTC Veterinary Drug Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global OTC Veterinary Drug Revenue Share by Application (2018-2024)
Table 31. Global OTC Veterinary Drug Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 32. Global OTC Veterinary Drug Revenue Share by Application (2024-2034)
Table 33. North America OTC Veterinary Drug Market Size by Type (2018-2024) & (US$ Million)
Table 34. North America OTC Veterinary Drug Market Size by Type (2024-2034) & (US$ Million)
Table 35. North America OTC Veterinary Drug Market Size by Application (2018-2024) & (US$ Million)
Table 36. North America OTC Veterinary Drug Market Size by Application (2024-2034) & (US$ Million)
Table 37. North America OTC Veterinary Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 38. North America OTC Veterinary Drug Market Size by Country (2018-2024) & (US$ Million)
Table 39. North America OTC Veterinary Drug Market Size by Country (2024-2034) & (US$ Million)
Table 40. Europe OTC Veterinary Drug Market Size by Type (2018-2024) & (US$ Million)
Table 41. Europe OTC Veterinary Drug Market Size by Type (2024-2034) & (US$ Million)
Table 42. Europe OTC Veterinary Drug Market Size by Application (2018-2024) & (US$ Million)
Table 43. Europe OTC Veterinary Drug Market Size by Application (2024-2034) & (US$ Million)
Table 44. Europe OTC Veterinary Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 45. Europe OTC Veterinary Drug Market Size by Country (2018-2024) & (US$ Million)
Table 46. Europe OTC Veterinary Drug Market Size by Country (2024-2034) & (US$ Million)
Table 47. China OTC Veterinary Drug Market Size by Type (2018-2024) & (US$ Million)
Table 48. China OTC Veterinary Drug Market Size by Type (2024-2034) & (US$ Million)
Table 49. China OTC Veterinary Drug Market Size by Application (2018-2024) & (US$ Million)
Table 50. China OTC Veterinary Drug Market Size by Application (2024-2034) & (US$ Million)
Table 51. Asia OTC Veterinary Drug Market Size by Type (2018-2024) & (US$ Million)
Table 52. Asia OTC Veterinary Drug Market Size by Type (2024-2034) & (US$ Million)
Table 53. Asia OTC Veterinary Drug Market Size by Application (2018-2024) & (US$ Million)
Table 54. Asia OTC Veterinary Drug Market Size by Application (2024-2034) & (US$ Million)
Table 55. Asia OTC Veterinary Drug Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 56. Asia OTC Veterinary Drug Market Size by Region (2018-2024) & (US$ Million)
Table 57. Asia OTC Veterinary Drug Market Size by Region (2024-2034) & (US$ Million)
Table 58. Middle East, Africa, and Latin America OTC Veterinary Drug Market Size by Type (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America OTC Veterinary Drug Market Size by Type (2024-2034) & (US$ Million)
Table 60. Middle East, Africa, and Latin America OTC Veterinary Drug Market Size by Application (2018-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America OTC Veterinary Drug Market Size by Application (2024-2034) & (US$ Million)
Table 62. Middle East, Africa, and Latin America OTC Veterinary Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 63. Middle East, Africa, and Latin America OTC Veterinary Drug Market Size by Country (2018-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America OTC Veterinary Drug Market Size by Country (2024-2034) & (US$ Million)
Table 65. Zoetis Company Details
Table 66. Zoetis Business Overview
Table 67. Zoetis OTC Veterinary Drug Product
Table 68. Zoetis Revenue in OTC Veterinary Drug Business (2018-2024) & (US$ Million)
Table 69. Zoetis Recent Developments
Table 70. Boehringer Ingelheim Company Details
Table 71. Boehringer Ingelheim Business Overview
Table 72. Boehringer Ingelheim OTC Veterinary Drug Product
Table 73. Boehringer Ingelheim Revenue in OTC Veterinary Drug Business (2018-2024) & (US$ Million)
Table 74. Boehringer Ingelheim Recent Developments
Table 75. Virbac S.A. Company Details
Table 76. Virbac S.A. Business Overview
Table 77. Virbac S.A. OTC Veterinary Drug Product
Table 78. Virbac S.A. Revenue in OTC Veterinary Drug Business (2018-2024) & (US$ Million)
Table 79. Virbac S.A. Recent Developments
Table 80. Hester Biosciences Ltd. Company Details
Table 81. Hester Biosciences Ltd. Business Overview
Table 82. Hester Biosciences Ltd. OTC Veterinary Drug Product
Table 83. Hester Biosciences Ltd. Revenue in OTC Veterinary Drug Business (2018-2024) & (US$ Million)
Table 84. Hester Biosciences Ltd. Recent Developments
Table 85. Merck Animal Health Company Details
Table 86. Merck Animal Health Business Overview
Table 87. Merck Animal Health OTC Veterinary Drug Product
Table 88. Merck Animal Health Revenue in OTC Veterinary Drug Business (2018-2024) & (US$ Million)
Table 89. Merck Animal Health Recent Developments
Table 90. Elanco Animal Health Company Details
Table 91. Elanco Animal Health Business Overview
Table 92. Elanco Animal Health OTC Veterinary Drug Product
Table 93. Elanco Animal Health Revenue in OTC Veterinary Drug Business (2018-2024) & (US$ Million)
Table 94. Elanco Animal Health Recent Developments
Table 95. Ceva Santé Animale Company Details
Table 96. Ceva Santé Animale Business Overview
Table 97. Ceva Santé Animale OTC Veterinary Drug Product
Table 98. Ceva Santé Animale Revenue in OTC Veterinary Drug Business (2018-2024) & (US$ Million)
Table 99. Ceva Santé Animale Recent Developments
Table 100. Vetoquinol S.A. Company Details
Table 101. Vetoquinol S.A. Business Overview
Table 102. Vetoquinol S.A. OTC Veterinary Drug Product
Table 103. Vetoquinol S.A. Revenue in OTC Veterinary Drug Business (2018-2024) & (US$ Million)
Table 104. Vetoquinol S.A. Recent Developments
Table 105. Phibro Animal Health Corporation Company Details
Table 106. Phibro Animal Health Corporation Business Overview
Table 107. Phibro Animal Health Corporation OTC Veterinary Drug Product
Table 108. Phibro Animal Health Corporation Revenue in OTC Veterinary Drug Business (2018-2024) & (US$ Million)
Table 109. Phibro Animal Health Corporation Recent Developments
Table 110. Dechra Pharmaceuticals PLC Company Details
Table 111. Dechra Pharmaceuticals PLC Business Overview
Table 112. Dechra Pharmaceuticals PLC OTC Veterinary Drug Product
Table 113. Dechra Pharmaceuticals PLC Revenue in OTC Veterinary Drug Business (2018-2024) & (US$ Million)
Table 114. Dechra Pharmaceuticals PLC Recent Developments
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global OTC Veterinary Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 2. Global OTC Veterinary Drug Market Share by Type: 2022 VS 2034
Figure 3. Oral Features
Figure 4. Injectable Features
Figure 5. Topical Features
Figure 6. Others Features
Figure 7. Global OTC Veterinary Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 8. Global OTC Veterinary Drug Market Share by Application: 2022 VS 2034
Figure 9. Veterinary Hospitals Case Studies
Figure 10. Veterinary Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. OTC Veterinary Drug Report Years Considered
Figure 13. Global OTC Veterinary Drug Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 14. Global OTC Veterinary Drug Market Size, (US$ Million), 2018 VS 2022 VS 2034
Figure 15. Global OTC Veterinary Drug Market Share by Region: 2022 VS 2034
Figure 16. Global OTC Veterinary Drug Market Share by Players in 2022
Figure 17. Global Top OTC Veterinary Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Veterinary Drug as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by OTC Veterinary Drug Revenue in 2022
Figure 19. North America OTC Veterinary Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 20. North America OTC Veterinary Drug Market Share by Type (2018-2034)
Figure 21. North America OTC Veterinary Drug Market Share by Application (2018-2034)
Figure 22. North America OTC Veterinary Drug Market Share by Country (2018-2034)
Figure 23. United States OTC Veterinary Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. Canada OTC Veterinary Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. Europe OTC Veterinary Drug Market Size YoY (2018-2034) & (US$ Million)
Figure 26. Europe OTC Veterinary Drug Market Share by Type (2018-2034)
Figure 27. Europe OTC Veterinary Drug Market Share by Application (2018-2034)
Figure 28. Europe OTC Veterinary Drug Market Share by Country (2018-2034)
Figure 29. Germany OTC Veterinary Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. France OTC Veterinary Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. U.K. OTC Veterinary Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Italy OTC Veterinary Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Russia OTC Veterinary Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Nordic Countries OTC Veterinary Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. China OTC Veterinary Drug Market Size YoY (2018-2034) & (US$ Million)
Figure 36. China OTC Veterinary Drug Market Share by Type (2018-2034)
Figure 37. China OTC Veterinary Drug Market Share by Application (2018-2034)
Figure 38. Asia OTC Veterinary Drug Market Size YoY (2018-2034) & (US$ Million)
Figure 39. Asia OTC Veterinary Drug Market Share by Type (2018-2034)
Figure 40. Asia OTC Veterinary Drug Market Share by Application (2018-2034)
Figure 41. Asia OTC Veterinary Drug Market Share by Region (2018-2034)
Figure 42. Japan OTC Veterinary Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. South Korea OTC Veterinary Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. China Taiwan OTC Veterinary Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Southeast Asia OTC Veterinary Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. India OTC Veterinary Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. Australia OTC Veterinary Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America OTC Veterinary Drug Market Size YoY (2018-2034) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America OTC Veterinary Drug Market Share by Type (2018-2034)
Figure 50. Middle East, Africa, and Latin America OTC Veterinary Drug Market Share by Application (2018-2034)
Figure 51. Middle East, Africa, and Latin America OTC Veterinary Drug Market Share by Country (2018-2034)
Figure 52. Brazil OTC Veterinary Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 53. Mexico OTC Veterinary Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 54. Turkey OTC Veterinary Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 55. Saudi Arabia OTC Veterinary Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 56. Israel OTC Veterinary Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 57. GCC Countries OTC Veterinary Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 58. Zoetis Revenue Growth Rate in OTC Veterinary Drug Business (2018-2024)
Figure 59. Boehringer Ingelheim Revenue Growth Rate in OTC Veterinary Drug Business (2018-2024)
Figure 60. Virbac S.A. Revenue Growth Rate in OTC Veterinary Drug Business (2018-2024)
Figure 61. Hester Biosciences Ltd. Revenue Growth Rate in OTC Veterinary Drug Business (2018-2024)
Figure 62. Merck Animal Health Revenue Growth Rate in OTC Veterinary Drug Business (2018-2024)
Figure 63. Elanco Animal Health Revenue Growth Rate in OTC Veterinary Drug Business (2018-2024)
Figure 64. Ceva Santé Animale Revenue Growth Rate in OTC Veterinary Drug Business (2018-2024)
Figure 65. Vetoquinol S.A. Revenue Growth Rate in OTC Veterinary Drug Business (2018-2024)
Figure 66. Phibro Animal Health Corporation Revenue Growth Rate in OTC Veterinary Drug Business (2018-2024)
Figure 67. Dechra Pharmaceuticals PLC Revenue Growth Rate in OTC Veterinary Drug Business (2018-2024)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed